OK HB2661

Establishes definitions related to opioid analgesic drugs for Oklahoma insurance law, to be codified in Title 36, Section 6060.21 of the Oklahoma Statutes

Defines "opioid analgesic drug product" as drugs in the opioid class used to treat moderate to severe pain, including both immediate release and extended release/long-acting forms

Defines "abuse-deterrent opioid analgesic drug product" as brand or generic opioids approved by the FDA with labeling claims indicating the product is expected to meaningfully reduce abuse

Defines "cost-sharing" to include coverage limits, copayments, coinsurance, deductibles, and other out-of-pocket expense requirements

Effective date of November 1, 2016